Providing preserved human cardiac and vascular tissues, surgical adhesives and sealants, prosthetic heart valves, cardiac lasers, and other medical devices.
Location: United States, Georgia, Kennesaw
Employees: 1001-5000
Founded date: 1984
Investors 1
| Date | Name | Website |
| - | Galen Part... | galen.com |
Mentions in press and media 15
| Date | Title | Description |
| 04.03.2024 | Structural Heart Devices Market Surges as Aging Population Spurs Cardiovascular Health Concerns | A structural heart disease is a non-coronary defect of the heart, thus not affecting the blood vessels in the heart. PORTLAND, OREGON, UNITED STATES, March 4, 2024 /EINPresswire.com/ -- According to a new report published by Allied Market R... |
| 18.01.2022 | CryoLife Announces Corporate Rebranding and Changes Name to Artivion | ATLANTA, Jan. 18, 2022 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it was renaming and rebranding itself to Artivion, Inc., effective immediately... |
| 20.10.2021 | CryoLife : Announces Release Date and Teleconference Call Details for Third Quarter 2021 Financial Results | ATLANTA, Oct. 20, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that third quarter 2021 financial results will be released on Thursday, November 4,... |
| 29.07.2021 | CryoLife Reports Second Quarter 2021 Financial Results | |
| 29.07.2021 | CryoLife Announces Sale of PerClot to Baxter | |
| 15.07.2021 | CryoLife : Announces Release Date and Teleconference Call Details for Second Quarter 2021 Financial Results | ATLANTA, July 15, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that second quarter 2021 financial results will be released on Thursday, July 29, 2... |
| 29.04.2021 | CryoLife Reports First Quarter 2021 Financial Results | |
| 15.04.2021 | CRYOLIFE, INC. CryoLife : Announces Release Date and Teleconference Call Details for First Quarter 2021 Financial Results | ATLANTA, April 15, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that first quarter 2021 financial results will be released on Thursday, April 29, ... |
| 15.04.2021 | CryoLife Announces Release Date and Teleconference Call Details for First Quarter 2021 Financial Results | |
| 09.03.2021 | CryoLife to Participate in Oppenheimer 31st Annual Virtual Healthcare Conference | ATLANTA, March 9, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the upcoming Oppenheimer 31st Annual Virtual Healthcare... |
Show more